Results 61 to 70 of about 22,449 (147)

Low-Dose Naltrexone in Chronic Pain Management: Mechanisms, Evidence, and Clinical Implications. [PDF]

J Pers Med
McKenzie A, Bittar T, Dombrower R, Raman D, Hussain H, Theeraphapphong N, McKenzie SM, Abd-Elsayed A.   +7 more
europepmc   +1 more source

Health Plan Disenrollment and Mortality After Initiation of Medications for Opioid Use Disorder. [PDF]

JAMA Psychiatry
Nguyen AP, Binswanger IA, Narwaney KJ, Goodrich G, Christine PJ, Campbell CI, Xu S, Loree AM, Glanz JM.   +8 more
europepmc   +1 more source

Toward Precision Obesity Pharmacotherapy: Using the Eating Behavior Phenotype Scale (EFCA) in Real-World Clinical Practice. [PDF]

Nutrients
Pineda-Wieselberg RJ, Soares AH, Napoli TF, Scalissi NM, Salles JEN.   +4 more
europepmc   +1 more source

Melatonergic Receptors Mediate Reduction in Ethanol Consumption in Wistar Rats. [PDF]

Biomolecules
Rather ZA, Ullal SD, Baregundi MY, Shenoy AK.   +3 more
europepmc   +1 more source

Longitudinal Patterns of Dental Health Care Utilization 18 Months Before and 36 Months After Initiation of Index Medications for Opioid Use Disorder. [PDF]

J Addict Med
Roy PJ, Yuan N, Li Y, Butler AM, Nickel KB, Gibson G, Hubbard CC, Boyer TL, Suda KJ, Durkin MJ.   +9 more
europepmc   +1 more source

Naltrexone/bupropion for binge-eating disorder: A human laboratory investigation of mechanisms. [PDF]

Drug Alcohol Depend Rep
McKee SA, Lydecker JA, Pittman B, Jastreboff AM, DiLeone RJ, Lavery M, Grilo CM.   +6 more
europepmc   +1 more source

Social context in renewal of cocaine and fentanyl seeking: role of peer presence versus peer absence. [PDF]

Psychopharmacology (Berl)
Blanchard ML, Humburg BA, Bardo MT.
europepmc   +1 more source

Would we, could we? Measuring attitudinal and capacity barriers to supporting recovery housing residents on medication for opioid use disorder. [PDF]

J Subst Use Addict Treat
Winograd RP, Park B, Ghonasgi R, Paschke M, Mericle AA.   +4 more
europepmc   +1 more source

Exploring the association between sweet liking and treatment response to naltrexone in patients with alcohol use disorder. [PDF]

Int J Neuropsychopharmacol
Chang MC, Chen CH, Meng SC, Shu SH, Chang HM, Huang MC.   +5 more
europepmc   +1 more source

New and emerging treatments for PBC-related pruritus. [PDF]

Drugs Context
Anderson SL.
europepmc   +1 more source